GT Biopharma (GTBP) had the highest return between January 1, 2015 and June 30, 2015 by a US stock, returning 2,393,358,135.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
GT Biopharma (GTBP) | 1/1/2015 - 6/30/2015 | 2,393,358,135.71% |
SurgePays (SURG) | 1/1/2015 - 6/30/2015 | 2,400% |
Cidara Therapeutics (CDTX) | 1/1/2015 - 6/30/2015 | 1,652.5% |
Patriot National Bancorp (PNBK) | 1/1/2015 - 6/30/2015 | 863.61% |
Focus Universal (FCUV) | 1/1/2015 - 6/30/2015 | 500.01% |
Celsius (CELH) | 1/1/2015 - 6/30/2015 | 465.87% |
FiEE (FIEE) | 1/1/2015 - 6/30/2015 | 457.76% |
FingerMotion (FNGR) | 1/1/2015 - 6/30/2015 | 400% |
Mawson Infrastructure (MIGI) | 1/1/2015 - 6/30/2015 | 280% |
Natural Health Trend (NHTC) | 1/1/2015 - 6/30/2015 | 255.12% |
Marker Therapeutics (MRKR) | 1/1/2015 - 6/30/2015 | 242.86% |
Tantech (TANH) | 1/1/2015 - 6/30/2015 | 214.17% |
Heron Therapeuti (HRTX) | 1/1/2015 - 6/30/2015 | 206.09% |
Metalla Royalty & Streaming (MTA) | 1/1/2015 - 6/30/2015 | 200% |
Quantum Computing (QUBT) | 1/1/2015 - 6/30/2015 | 200% |
Sharplink Gaming (SBET) | 1/1/2015 - 6/30/2015 | 177.78% |
Galapagos NV ADR (GLPG) | 1/1/2015 - 6/30/2015 | 171.68% |
Fluent (FLNT) | 1/1/2015 - 6/30/2015 | 169.11% |
Travere Therapeutics (TVTX) | 1/1/2015 - 6/30/2015 | 168.86% |
Cocrystal Pharma (COCP) | 1/1/2015 - 6/30/2015 | 165.12% |
Exelixis (EXEL) | 1/1/2015 - 6/30/2015 | 155.78% |
eXp World (EXPI) | 1/1/2015 - 6/30/2015 | 154.26% |
Amarin (AMRN) | 1/1/2015 - 6/30/2015 | 151.02% |
Prothena (PRTA) | 1/1/2015 - 6/30/2015 | 150.81% |
Assembly Biosciences (ASMB) | 1/1/2015 - 6/30/2015 | 149.81% |
